# Raphael Pharmaceutical Inc. (RAPH)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RAPH/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -769.0K | $ -215.0K | $ 0 | $ -1.43M |
| 2024 | $ 0 | $ -1.02M | $ -228.1K | $ 41.0K | $ -742.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | -1.04 |
| Current Ratio | 0.03 |

## Other views

- [Metrics](https://sponda.capital/en/RAPH.md)
- [Charts](https://sponda.capital/en/RAPH/charts.md)
- [Compare](https://sponda.capital/en/RAPH/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.